ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ANIK vs OSUR // NET PROFIT MARGIN

Anika Therapeutics Inc. (NASDAQ) VS. OraSure Technologies Inc. (NASDAQ) • 15-METRIC TALLY: ANIK 9 — OSUR 0
▲ NET PROFIT MARGIN LEADER: ANIK
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ANIK VS. OSUR) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ANIK OSUR SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 56.60% 41.90% +14.70 ANIK /gross-margins <GO>
Return on Invested Capital (ROIC) -10.20% -35.00% +24.80 ANIK /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield 1.50% -18.91% +20.41 ANIK /fcf-yield <GO>
Operating Margin -9.80% -60.00% +50.20 ANIK /operating-margins <GO>
Net Profit Margin ACTIVE -9.80% -59.80% +50.00 ANIK /net-margins <GO>
Revenue Growth (YoY) -5.90% -38.10% +32.20 ANIK /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 2.47 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 6/9 3/9 +3.00 ANIK /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 60.4 57.0 +3.40 ANIK /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $291.6M $281.4M $10.2M ANIK /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ANIK REV OSUR REV ANIK GROSS % OSUR GROSS % ANIK FCF OSUR FCF
FY 2025 $112.8M $115.0M 56.6% 41.9% $4.4M -$53.2M
FY 2024 $119.9M $185.8M 63.4% 42.7% -$2.3M $23.6M
FY 2023 $120.8M $405.5M — — -$1.8M $141.6M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ANIK // BETA —
OSUR // BETA —